Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivastigmine Transdermal Patch

Approval Number

国药准字HJ20200018

CompanyLuye Pharma AG

Registration Date

March 25, 2025

Previous Approval Numbers

H20200018

Drug Information

Generic Name

利斯的明透皮贴剂

Dosage Form

贴剂

Strength

4.6mg/24小时

Drug Type

化学药品

Registration Date

March 25, 2025

Expiry Date

March 24, 2030

Company Information

Applicant Company

Company NameLuye Pharma AG

Company Address

Am Windfeld 35, 83714 Miesbach

Manufacturing Company

Company NameLuye Pharma AG

Company Address

Am Windfeld 35, 83714 Miesbach

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy